Background. Magnetic resonance imaging (MRI) is increasingly being used for rectal cancer staging. The purpose of this study was to determine the accuracy of phased array MRI for T category (T1-2 vs. T3-4), lymph node metastases, and circumferential resection margin (CRM) involvement in primary rectal cancer. Methods. Medline, Embase, and Cochrane databases were searched using combinations of keywords relating to rectal cancer and MRI. Reference lists of included articles were also searched by hand. Inclusion criteria were: (1) original article published January 2000-March 2011, (2) use of phased array coil MRI, (3) histopathology used as reference standard, and (4) raw data available to create 2 9 2 contingency tables. Patients who underwent preoperative long-course radiotherapy or chemoradiotherapy were excluded. Two reviewers independently extracted data. Sensitivity, specificity, and diagnostic odds ratio were estimated for each outcome using hierarchical summary receiver-operating characteristics and bivariate random effects modeling.
Results. Twenty-one studies were included in the analysis. There was notable heterogeneity among studies. MRI specificity was significantly higher for CRM involvement [94%, 95% confidence interval (CI) 88-97] than for T category (75%, 95% CI 68-80) and lymph nodes (71%, 95% CI 59-81). There was no significant difference in sensitivity between the three elements as a result of wide overlapping CIs. Diagnostic odds ratio was significantly higher for CRM (56.1, 95% CI 15.3-205.8) than for lymph nodes (8.3, 95% CI 4.6-14.7) but did not differ significantly from T category (20.4 , 95% CI 11.1-37.3). Conclusions. MRI has good accuracy for both CRM and T category and should be considered for preoperative rectal cancer staging. In contrast, lymph node assessment is poor on MRI.
Although preoperative radiotherapy (RT) and preoperative chemoradiotherapy (CRT) have been shown to greatly decrease the risk of local recurrence after surgery for rectal cancer, these treatment protocols do not affect survival and lead to poorer functional outcomes (i.e., bowel and sexual function) compared to surgery alone. 1, 2 Although understaging rectal cancer may lead to omission of preoperative RT and CRT and an increased risk of local recurrence, overstaging may lead to unnecessary treatment with preoperative RT and CRT, with important functional consequences. Therefore, accurate local staging of rectal cancer is essential to select patients for preoperative treatment. Staging elements including T category, lymph node metastases, and circumferential resection margin (CRM) involvement are key prognosticators of local recurrence risk and are emphasized to different degrees in various treatment guidelines for rectal cancer. 3 Although four previous meta-analyses have investigated the accuracy of magnetic resonance imaging (MRI) for local staging of primary rectal cancer, none of these studies has directly compared MRI performance for all three of these specific elements. [4] [5] [6] [7] Therefore, the objective of this study was to perform a systematic review and meta-analysis regarding the accuracy of phased array pelvic MRI in rectal cancer for determining T category, lymph node metastases, and CRM involvement. , and the Cochrane Database of Systematic Reviews (2005-March 2011) was performed using search terms related to MRI, rectal cancer, neoplasm staging, and diagnostic assessment (Appendix A). Reference lists of articles retrieved were also searched manually to identify relevant studies.
Studies were included in the systematic review if they fulfilled the following a priori defined criteria: (1) original published reports with primary data, (2) phased array MRI coil, (3) histopathology used as the reference standard, and (4) English language. To ensure that technology under assessment was relatively current, final results were restricted to studies published since January 2000. Studies in which original primary data were available to extract or reconstruct 2 9 2 contingency tables for the outcomes of interest were eligible for inclusion in the meta-analysis. Where raw data were not published but an article was otherwise eligible for inclusion, authors were contacted to request this information.
Excluded from the meta-analysis were the following: (1) studies that incorporated other MRI coil types (e.g., endorectal or body coil) that were deemed to represent a fundamentally different index test and are less widely used in practice, (2) duplicate data from another included study, and (3) inclusion of patients who received preoperative CRT or long-course RT alone (excluded because of downstaging). In cases where only a portion of the study population met the inclusion criteria (e.g., some patients received preoperative RT and some did not), only data for those eligible patients were included in the analysis if it could be extracted separately.
Titles and abstracts identified by the search strategy were independently reviewed by three reviewers. For all abstracts that met the inclusion criteria or were potentially eligible, full articles were retrieved and independently reviewed by two reviewers.
Data Extraction
Data from selected articles were independently abstracted by two reviewers who used a standardized data extraction form and included study variables (year of publication, study design), test interpretation variables (definitions for MRI ''positive cases,'' number of readers, approach to image assessment), population characteristics (inclusion and exclusion criteria), MRI protocol (field strength, sequences, resolution parameters, contrast use), and test results (2 9 2 contingency tables). Each article was then discussed among all reviewers and discrepancies were resolved by consensus. In studies where separate results were provided for multiple independent readers, each set of results was included as a separate data set.
Two-by-two contingency tables were extracted or reconstructed for each outcome on a patient level as follows: T category (T3/T4 vs. T1/T2); lymph nodes (any involved vs. all clear); and CRM (involved vs. clear). These categories were developed to determine the accuracy of MRI to appropriately select patients for preoperative CRT 3 .
Assessment of Methodologic Quality
A modified version of the Quality Assessment of Diagnostic Accuracy Studies (QUADAS) tool was used to assess the methodologic quality of studies included in the meta-analysis (Appendix B). 8 Minimum criteria for fulfilling each QUADAS item were discussed by reviewers, and disagreements were resolved by consensus. Each quality item was scored as ''yes,'' ''no,'' or ''unclear.'' In keeping with Cochrane DTA Working Group recommendations, no summary score was calculated because this obscures the importance of individual quality items and can lead to inaccurate conclusions. 9 
Statistical Analysis and Data Synthesis
Statistical analysis was performed by using bivariate random effects modeling and hierarchical summary receiver-operating characteristics modeling. These recently developed statistical approaches are advocated by the Cochrane Collaboration for use in meta-analyses of diagnostic test accuracy. 10 Both models use a random effects approach that assumes that variability between study results is due not only to random sampling error but also to true differences between studies (e.g., populations, thresholds). Important advantages of this approach are that it accounts for variability both within and between studies and allows exploration of sources of heterogeneity through inclusion of covariates in the model. 11, 12 Using SAS software (SAS institute, Cary, NC), bivariate random effects modeling was used to produce summary estimates of sensitivity and specificity, while hierarchical summary receiver-operating characteristics modeling was used to estimate the diagnostic odds ratio (DOR) for each outcome. Once parameter estimates were obtained, the Cochrane Collaboration's Review Manager software (RevMan 5) was used to fit summary receiver-operating characteristic (ROC) curves. These curves show the point estimates and confidence regions for sensitivity and specificity and illustrate how sensitivity and specificity change as thresholds vary for each staging element. The closer the point estimate and curve is to the upper left corner of the plot, the better its overall diagnostic performance.
Investigations of Heterogeneity
The following covariate analyses were planned for each outcome: MRI protocol (adequate vs. inadequate), field strength (3 T vs. lower fields), definition of T3 tumor (nodular vs. spiculated tumor margin), definition of lymph node metastatic involvement (size vs. border vs. signal criteria), definition of CRM involvement (\1 mm vs. \2 mm), and approach to image assessment (independent vs. consensus). MRI protocols were deemed adequate if they included T2-weighted, high-resolution axial images performed perpendicular to the long axis of tumor-bearing rectum. A sensitivity analysis was also planned to investigate the influence of individual quality items on results.
RESULTS

Search Results and Study Selection
The initial literature search identified 1,145 abstracts, of which 95 were judged relevant for full assessment; an additional 9 articles were identified from the reference lists of these articles and were also read in full. After data extraction, 21 articles met the inclusion criteria and have been included in this meta-analysis. Requests for original data from authors of 14 potentially eligible articles yielded no further information, and these were therefore excluded. The remaining articles did not meet inclusion criteria for a number of reasons and were excluded (Fig. 1 ).
Study Characteristics
Data were extracted from 19 studies for T category assessment in 1986 patients (33 data sets), from 12 studies for lymph node assessment in 1249 patients (23 data sets), and from 10 studies for CRM assessment in 986 patients (13 data sets). Characteristics of included studies are summarized in Table 1 . The study design was retrospective, prospective, and unclear in 8, 11, and 2 studies, respectively. Six studies employed a consensus of two radiologists, and 14 recorded independent readings of one or more radiologists; this information was not available in one study. There was notable heterogeneity among studies in the criteria used to define ''positive'' cases, and this information was frequently not provided. In the assessment of T category, ''spiculated'' extensions from the tumor into the perirectal fat were considered T3 tumor in some studies and T2 tumor in others. Lymph node size C5 mm, irregular borders, and mixed signal intensity were used in different combinations across studies to define lymph node metastatic involvement. CRM involvement was most variably defined, ranging from direct contiguity of tumor with the mesorectal fascia to tumor extension B5 mm from the mesorectal fascia.
Methodologic Quality
The methodologic quality of included studies is summarized in Table 2 . As per the inclusion criteria, all studies used an acceptable reference standard (histopathology). In general, poor reporting of study details prohibited assessment of studies on a number of quality items. In particular, the patient spectrum as well as the specific MRI and histologic assessment protocols were commonly not reported and were the main contributors to this problem.
Data Analysis
For each outcome, summary estimates of sensitivity, specificity, and DOR were produced with 95% confidence intervals (CIs) ( Table 3) , and summary ROC curves were fitted with 95% confidence regions (Fig. 2) . MRI specificity was significantly higher for CRM involvement (94%, 95% CI 88-97) than for T category (75%, 95% CI 68-80) and lymph node metastases (71%, 95% CI 59-81). There was no significant difference in sensitivity between the three elements as a result of wide overlapping CIs. DOR was significantly higher for CRM (56.1, 95% CI 15.3-205.8) than for lymph node metastases (8.3, 95% CI 4.6-14.7) but did not differ significantly from T category DOR (20.4, 95% CI 11.1-37.3).
Covariate Analyses
Covariate analysis was performed to explore the influence of approach to image assessment, MRI field strength, and adequacy of MRI protocol on T category assessment ( Table 4 ). Studies that used a consensus approach to image assessment produced significantly higher estimates of sensitivity (P = 0.03) and DOR (P = 0.02) than those in which images were reviewed independently. MRI field strength also influenced estimates, as studies that used 3-T machines increased the specificity of MRI compared with 1-T or 1.5-T machines (P = 0.03). MRI protocol did not have a significant impact on MRI performance.
There were insufficient numbers to introduce other covariates into the statistical model as planned. However, because the widest CIs were associated with sensitivity of CRM involvement and the summary ROC plot suggested that this may be due to three outlying studies, a post hoc sensitivity analysis was performed to investigate the influence of excluding these three studies on MRI sensitivity for CRM involvement. 21, 26, 29 This analysis produced a higher estimate of sensitivity but had little effect on the width of the CI (93%, 95% CI 64-99).
DISCUSSION
In this meta-analysis, strict inclusion criteria and methodology were used to compare MRI performance for assessment of T category, lymph node metastases, and CRM involvement. The results show that MRI is more specific for CRM involvement than for T category, but its sensitivity for the two elements is not significantly different. T category assessment was improved with the use of higher field strength MRI machines and review of images by consensus of two or more radiologists. Previous meta-analyses have suggested that MRI may be superior for CRM assessment than for T category, but these studies did not directly compare the two elements. 4, 5, 7 Although the results of this analysis are largely in keeping with those of previous studies, the slight discrepancy in conclusions is likely attributable to differences in inclusion criteria and statistical approach. Other limitations of previous analyses are the inclusion of older studies with outdated technology (body coil), and the inclusion of patients who received preoperative CRT in the analysis. 4, 5, 7 In contrast to its performance for T category and CRM, MRI performance was more consistently poor for detection of lymph node metastases as demonstrated by a low DOR with relatively narrow CIs. These results are comparable to those of previous meta-analyses and suggest an inherent limitation in the capacity of current MRI technology to detect lymph node metastases accurately. [4] [5] [6] This problem is exacerbated by the lack of agreement on optimal criteria to assess lymph nodes. A new approach utilizing ultrasmall superparamagnetic iron oxide to enhance nodes on MRI is under investigation and has shown promising results in rectal cancer. [34] [35] [36] As with all meta-analyses of diagnostic accuracy studies, an important limitation of this analysis is the degree of heterogeneity between studies, including differences in clinical definitions of staging elements, approach to preoperative treatment decisions, MRI protocols, radiologist experience and approach to image interpretation, and methodologic quality. This heterogeneity has been managed in three main ways. First, focused inclusion criteria have been applied to minimize differences among study populations and technology. Second, a rigorous statistical approach has been utilized to incorporate heterogeneity into estimates and reflect its extent in the range of possible values (95% CIs), with covariate analyses performed when possible to explore the role of different variables. Third, a formal assessment of methodologic quality using a validated tool (QUADAS) has been performed to describe potential sources of heterogeneity.
Statistical heterogeneity was greatest in CRM sensitivity estimates and did not appear to diminish when the three studies with low sensitivity were excluded in a sensitivity analysis, suggesting that the variability could not be explained by these outlying points alone. 19, 24, 27 A threshold effect related to different definitions of CRM involvement is likely an important contributor to this heterogeneity, as wider cutoffs produce higher sensitivity and lower specificity estimates, while the reverse is true for narrower cutoffs. We had planned to explore the impact of individual study variables, including CRM cutoffs, on heterogeneity through covariate analyses; however, this could not be completed because of insufficient numbers. Incomplete reporting of study methodology (e.g., patient spectrum, MRI protocol, histologic assessment protocol) was a common finding and contributed to this problem.
A second limitation of this analysis is the exclusion of patients who underwent preoperative CRT. Because preoperative CRT was allocated on the basis of MRI findings (using T category and nodes in some cases, CRM in others), excluding those patients can result in apparently lower sensitivity and higher specificity, as analysis will identify cases that were understaged (i.e., those who should have received CRT but did not) but will fail to identify most of CI confidence interval, CRM circumferential resection margin, DOR diagnostic odds ratio 2 Estimated summary receiver-operating characteristic (sROC) curve of magnetic resonance imaging (MRI) for assessment of T category, mesorectal lymph node metastases, and circumferential resection margin (CRM) involvement in rectal cancer. Solid lines represent the range of possible pairs of (sensitivity, specificity) for each staging element; circles represent the summary point estimates with associated 95% confidence regions (dotted lines) for each staging element those that were overstaged (i.e., those who should not have received CRT but did). Including these patients is equally problematic, however, because CRT administered after MRI may downstage the tumor so that final histopathology no longer represents an appropriate reference standard for the original MR image. This problem applies to all metaanalyses of this topic. To determine the extent to which sensitivity and specificity were influenced by the strategy for allocation of CRT, it would be necessary to examine individual studies for their criteria for administering CRT, the proportion of patients who underwent this treatment, and the results of histopathology in those patients. Such analysis was not possible in our review, as much of this information was not available.
Our review identified a number of additional points that could not be synthesized in the meta-analysis. One interesting finding was that the extramural depth of invasion (EMD) (i.e., depth of tumor invasion beyond the muscularis propria) is used in some centers as an alternative to T category, such that patients with EMD of C5 mm receive preoperative CRT, while those with EMD of\5 mm without CRM involvement proceed directly to surgery. 37 The same authors showed that measurements of EMD on MRI and histopathology are equivalent within a mean difference of ±0.05 mm. 32 . However, agreement between MRI and histopathology measurements decreased for EMD of [5 mm. 38 A recent study found that MRI determination of EMD status (B5 mm vs. 5 mm) was no more accurate than T category (T3 vs. T1-2) assessment (88 and 91%, respectively). 27 . With respect to CRM assessment, Beets-Tan et al. 39 retrospectively investigated the correlation between CRM measurement on phased array MRI and pathology and concluded that MRI CRM of at least 5 mm is required to predict with high certainty a histologic CRM of at least 1 mm. This study suggested that MRI prediction of CRM involvement is reliable but that accurate assessment may require the use of a wider threshold on MRI compared to pathology. However, a recent prospective study by Taylor et al. 37 showed that a cutoff of[1 mm on MRI can be used to predict clear margins with a low positive histologic CRM rate (3.3%).
It is important to note that, in order to maintain consistency with the terminology used in the literature, this meta-analysis has used the term CRM to describe the MRI predicted distance to the mesorectal fascia. However, it has been pointed out that this terminology is inappropriate in the preoperative setting, given that CRM is determined by the extent of surgical resection that cannot be predicted on MRI. 40 Instead, experts now recommend the use of the term ''mesorectal fascia'' for MRI-based staging or describing the relationship of the tumor to the sphincters in the case of low rectal tumors. 41 With respect to lymph nodes, although short axis diameter [5 mm was the criterion most commonly used to predict lymph node metastases on MRI, our review found little evidence to support this particular cutoff. In fact, one study found that 15% of lymph nodes B5 mm on MRI were involved with metastatic disease, suggesting that there is no size limit below which nodal metastasis can be ruled out. 42 Studies that have specifically investigated optimal criteria for detecting metastatic nodes have demonstrated improved sensitivity and specificity with use of border and/or signal criteria relative to size alone. [42] [43] [44] However, such criteria can be more subjective and less reliable among different observers. 26 In conclusion, MRI is very specific for assessment of CRM involvement, and its sensitivity for this parameter is similar to T category. CRM and T category are complementary indicators of the need for preoperative CRT, and both should be taken into account. These results support the use of MRI in preoperative staging of rectal cancer. The use of MRI with higher field strength and reviewing images in consensus with a second radiologist are strategies that can increase the sensitivity and specificity of MRI for T category assessment. In contrast to T category and CRM, lymph node assessment is poor on MRI, and approaches to improve it should be further investigated.
Heterogeneity remains a problem for meta-analyses of diagnostic accuracy studies and arises from differences in populations, methodology, and test parameters including definitions of positive cases. Definitions of essential staging elements and MRI protocols should be standardized to reduce heterogeneity in future studies. Multislice Quirke method used to assess histopathology specimen
As recommended by the Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy (DTA), the three items relating to quality of reporting (rather than methodology) were omitted from the quality assessment. Items 12 and 13 are not part of the original QUADAS tool but were added by the reviewers because they were relevant to studies of MRI diagnostic accuracy a Rationale: sufficient proportions of T2 and T3 tumors must be present to represent their true prevalence and adequately test observers' ability to distinguish between them
